DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Baena-Cagnani CE, Teijeiro A, Canonica GW.
Four-year follow-up in children with moderate/severe uncontrolled asthma after withdrawal of a 1-year omalizumab treatment.
Curr Opin Allergy Clin Immunol 2015;
15 (03) 267-271
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.